Products
17432 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 104.02 | 0.56 | 0.030 | 0.59 | 1 | -42.86% | -64.56% | -59.71% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 104.02 | 1.05 | 0.040 | 1.09 | 1 | -34.78% | -56.07% | -50.24% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 104.02 | 0.11 | 0.030 | 0.14 | 1 | -38.89% | -52.17% | -47.62% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 375.164 | 12.54 | 0.180 | 12.72 | 1 | 63.07% | -18.52% | -27.97% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 375.164 | 0.024 | ― | ― | 1 | 20.00% | 60.00% | 60.00% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450967372 | Novo Nordisk | Constant Leverage | Long | ― | 375.164 | 0.003 | ― | ― | 1 | 50.00% | 200.00% | 200.00% | 9 Jul. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 375.164 | 14.19 | 0.170 | 14.36 | 1 | 47.51% | -10.87% | -14.16% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 375.164 | 0.009 | ― | ― | 1 | 0.00% | 800.00% | 800.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 375.164 | 0.009 | ― | ― | 1 | 0.00% | 800.00% | 800.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396327889 | Novo Nordisk | Constant Leverage | Long | ― | 375.164 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 29 Jan. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968479 | Novo Nordisk | Constant Leverage | Long | ― | 375.164 | 14.73 | 0.130 | 14.86 | 1 | 31.28% | -5.03% | -4.16% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 375.164 | 5.33 | 0.090 | 5.42 | 1 | -30.51% | -7.63% | -23.75% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 375.164 | 0.43 | 0.030 | 0.46 | 1 | -45.57% | -17.31% | -41.89% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 375.164 | 0.24 | 0.030 | 0.27 | 1 | -58.62% | -29.41% | -60.66% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1199369815 | Nvidia | Constant Leverage | Long | ― | 187.392 | 26.74 | 0.050 | 26.79 | 1 | 1.56% | 30.63% | 26.13% | 27 Jun. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1246614460 | Nvidia | Constant Leverage | Long | ― | 187.392 | 4.22 | 0.020 | 4.24 | 1 | 1.69% | 37.01% | 28.27% | 3 Feb. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1246615640 | Nvidia | Constant Leverage | Long | ― | 187.392 | 0.76 | 0.010 | 0.77 | 1 | 0.00% | 33.33% | 24.59% | 8 Jun. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1423415673 | Nvidia | Constant Leverage | Long | ― | 187.392 | 212.27 | 0.820 | 213.09 | 1 | 3.30% | 66.51% | 29.76% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1119068000 | Nvidia | Constant Leverage | Long | ― | 187.392 | 177.88 | 0.350 | 178.23 | 1 | 1.19% | 24.11% | 22.29% | 12 May. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1362350113 | Nvidia | Constant Leverage | Long | ― | 187.392 | 0.012 | ― | ― | 1 | 0.00% | 9.09% | 9.09% | 12 Aug. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.